Combined long-term treatment of hemosiderosis with desferioxamine and DTPA in homozygous beta-thalassemia.
D000293:Adolescent; D000328:Adult; D001803:Blood Transfusion; D002648:Child; D003676:Deferoxamine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000378:metabolism; D005243:Feces / Q000737:chemistry; D006486:Hemosiderosis / Q000188:drug therapy* / Q000209:etiology; D006720:Homozygote; D006801:Humans; D007501:Iron / Q000032:analysis / Q000097:blood / Q000378:metabolism / Q000652:urine; D007504:Iron Radioisotopes; D004369:Pentetic Acid / Q000627:therapeutic use*; D013156:Splenectomy; D013789:Thalassemia / Q000150:complications* / Q000235:genetics; D013997:Time Factors
D007504:Iron Radioisotopes; D004369:Pentetic Acid; D007501:Iron; D003676:Deferoxamine